Takeda Pharmaceutical (TAK) Times Interest Earned (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Times Interest Earned of -$3.15 for Q2 2026, down 83.16% year-over-year from -$18.74 in Q2 2025, and down 67.92% quarter-over-quarter from -$1.88 in Q1 2026.
Takeda Pharmaceutical (TAK) Times Interest Earned (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$3.15 for Q2 2026.
- In Q2 2026, Times Interest Earned fell 83.16% year-over-year to -$3.15; the TTM figure through Jun 2026 stood at -$0.76 (up 53.52% YoY), while the FY2026 annual figure was $0.02, down 98.93% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$3.15, down from -$1.88 in the prior quarter.
- The five-year high for Times Interest Earned was $7.66 in Q4 2025, with the low at -$3.15 in Q2 2026.
- The 5-year median for Times Interest Earned is -$1.91 (2026), against an average of -$1.33.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned tumbled 386.21% in 2023, then surged 414.74% in 2025.
- Takeda Pharmaceutical's Times Interest Earned stood at -$1.84 in 2022, then climbed by 2.3% to -$1.8 in 2023, then jumped by 182.69% to $1.49 in 2024, then soared by 414.74% to $7.66 in 2025, then slumped by 141.16% to -$3.15 in 2026.
- Business Quant data shows TAK's Times Interest Earned at -$3.15 in Q2 2026, -$1.88 in Q1 2026, and $7.66 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.15 |
| Mar 31, 2026 | -1.88 |
| Dec 31, 2025 | 7.66 |
| Sep 30, 2025 | -1.35 |
| Jun 30, 2025 | -1.72 |
| Mar 31, 2025 | -1.72 |
| Dec 31, 2024 | 1.49 |
| Sep 30, 2024 | -2.42 |
| Jun 30, 2024 | -2.79 |
| Mar 31, 2024 | -2.82 |
| Dec 31, 2023 | -1.80 |
| Sep 30, 2023 | -2.33 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -2.83 |
| Dec 31, 2022 | -1.84 |
| Sep 30, 2022 | -1.94 |
| Jun 30, 2022 | -2.71 |
| Mar 31, 2022 | 0.99 |
| Dec 31, 2021 | -2.49 |
| Sep 30, 2021 | -2.46 |